Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

Total article views   HTML views PDF downloads Totals
14,702 Dovepress* 13,604+ 1,872 15,476
PubMed Central* 1,098 222 1,320
Totals 14,702 2,094 16,796
*Since 10 January 2017
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar